A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Advanced Breast Cancer in China
Clinical trial NCT05732428 · COMPLETED
Trial details
- NCT number
- NCT05732428
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-20
- Primary completion
- 2024-03-29
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.